Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Wake Forest University Health Sciences
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
Massachusetts General Hospital
University of Miami
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Brown University
Memorial Sloan Kettering Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
University of Iowa
Thomas Jefferson University
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
University of Rochester
Affiliated Hospital of Qinghai University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
Asan Medical Center
Rigshospitalet, Denmark
University of Nebraska
Northwestern University
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Cancer Support Community, Research and Training Institute, Philadelphia
Qianfoshan Hospital
OHSU Knight Cancer Institute
City of Hope Medical Center
Beth Israel Deaconess Medical Center